Dr Sumit (Sam) Garg on the risks of failing to preoperatively diagnose this highly prevalent condition. Medscape Ophthalmology
Tag: Ophthalmology
FDA OKs Fluocinolone Intravitreal Implant (Yutiq) for Uveitis
In clinical trials, Yutiq significantly reduced recurrence rates at 6 and 12 months following treatment compared with sham treatment in patients with chronic, noninfectious posterior segment uveitis. FDA Approvals
Drug Releasing Contact Lens Changes Color to Show When Its Working
Drugs designed to treat eye conditions are often delivered via eye drops. Almost all of the actual drug ends up dripping off the eye and not being properly absorbed. Drug releasing contact lenses are the next big thing to treat conditions such as glaucoma, and they may end up being pretty smart in addition to […]
Falls in Elders May Be Driving Up Secondary Diagnoses Of Eye Trauma
Hospital admissions due to eye trauma have declined since 2001, but more and more patients are being admitted with a secondary diagnosis of eye trauma, largely due to an increase in falls among older people, new findings suggest. Reuters Health Infor…
RightEye Secures FDA 510(k) Clearance for Eye-Tracking Platform
A couple months ago, Medgadget reviewed RightEye’s EyeQ vision tests and training tools in addition to speaking with Co-Founder and CSO Dr. Melissa Hunfalvay. As a platform to help providers assess eyesight, brain and reading disorders, and performance issues, RightEye captures much of its data using state-of-the-art eye tracking technol (Read more...)
A Visual Field Defect in a Patient With History of Seizures
A 64-year-old woman comes to you after 2 weeks of symptoms. Between visual testing and MRI, can you offer her a diagnosis? Medscape Ophthalmology
Zeiss Gets Approval for ReLEx SMILE for Myopia Treatment for People with Astigmatism
Zeiss won FDA approval for its ReLEx SMILE product for performing myopia treatment on patients with astigmatism. The product is offered on the company’s VisuMax femtosecond laser system, allowing the creation of a lenticule inside the cornea and access incision in one step. The laser is used to create millions of “photodisruptions& (Read more...)
High Dose of Sildenafil Tied to Long-term Retinal Damage
Persistent red-tinted vision and cone photoreceptor damage were reported in a patient who had taken a large dose of the erectile dysfunction drug sildenafil. Medscape Medical News
In-Clinic Hurdles for AI-Based Diabetic Retinopathy Detection
High numbers of false positives and poor image quality were found when an artificial intelligence system for diabetic retinopathy detection was tested in a primary care setting. Medscape Medical News
Heidelberg Engineering’s OCT Angiography FDA Cleared for Eye Assessments
Heidelberg Engineering, based in Franklin, MA, won FDA clearance for its OCT (optical coherence tomography) Angiography Module for the company’s SPECTRALIS eye imaging systems. The offering, used to visualize retinal vasculature in 3D, is available not only on new SPECTRALIS installations, but on existing upgradeable systems as well. OCT Angi (Read more...)
Developments in Benign Essential Blepharospasm Treatment
Get up-to-date on the latest advancements in the treatment options for benign essential blepharospasm. Current Opinion in Ophthalmology
When Dismissing a Patient, Avoid a ‘Bad Breakup’
Breaking up is always hard to do–particularly when it’s with a difficult patient. Take these steps to ensure a smooth transition. Medscape Optometry
EU Panel Recommends Luxturna for Inherited Retinal Dystrophy
The EMA’s CHMP has recommended marketing authorization for voretigene neparvovec for inherited retinal dystrophy caused by RPE65 gene mutations in adults and children. International Approvals
FDA Clears New Form of Latanoprost (Xelpros) for Glaucoma
Xelpros is the first and only form of latanoprost that is not formulated with benzalkonium chloride, a preservative commonly used in topical ocular preparations. FDA Approvals
(S)pot Check on Alternative Treatments for Glaucoma
Does marijuana, gingko biloba, or bilberry effectively manage symptoms of glaucoma? Medscape Ophthalmology
Anti-VEGF Effective in Persistent Diabetic Macular Edema
A recent analysis associated three different anti-VEGF agents with meaningful vision gains through 2 years of follow-up. Medscape Ophthalmology
Anti-VEGF vs PRP for Proliferative Diabetic Retinopathy
Five-year data from DRCR.net Protocol S provides needed comparative data on the efficacy, safety, and burden of these treatments. Medscape Ophthalmology
NIH Vision Researcher Among Seven to Receive Top Global Award
T. Michael Redmond and six others were honored for developing gene therapy for the blinding disorder Leber congenital amaurosis. It is the only pharmacologic treatment for an inherited retinal disease. Medscape Medical News
RightEye Vision Tests for Eyes and Brain: Interview with Co-Founder and CSO Dr. Melissa Hunfalvay
Medgadget recently demoed RightEye’s vision tests with Dr. Jennifer Kungle, a provider at The Center for Vision Development, and worked with the beta version of the company’s at-home EyeQ Trainer. It was a great experience that this editor would recommend for patients going through vision rehabilitation or individuals seeking a more viv (Read more...)
Alcon Pulls CyPass Glaucoma Micro-Stent Off the Global Market
The company cites 5-year safety data that show statistically significant endothelial cell loss in patients who received the CyPass stent at the time of glaucoma surgery. News Alerts